Physician profile
Anjali Mehta
NPI 1760603443
$2,443.00
in general payments reported to CMS, 2019-2025
26 companies · $462 in 2025
The $462 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $290 · 2021: $410 · 2022: $226 · 2023: $279 · 2024: $323 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $688.69 | 2019-2023 | |
| Coopersurgical, INC. | $253.03 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $201.47 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $141.75 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Aptima |
| Exeltis, USA INC. | $134.26 | 2019-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $113.29 | 2019-2025 | |
| Avion Pharmaceuticals | $98.68 | 2019-2021 | |
| Pfizer INC. | $96.80 | 2024 | |
| Therapeuticsmd, INC. | $95.85 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $92.49 | 2019-2020 | |
| Biogen, INC. | $87.23 | 2025 | Zurzuvae |
| Allergan, INC. | $72.53 | 2019-2020 | |
| Organon LLC | $42.96 | 2021-2025 | Nexplanon |
| Gynesonics, INC. | $38.87 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $35.40 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $32.81 | 2019 | |
| Boston Scientific Corporation | $30.36 | 2019 | |
| Mayne Pharma Commercial LLC | $29.71 | 2024 | |
| Daiichi Sankyo INC. | $29.52 | 2022 | |
| Seqirus USA INC | $22.89 | 2024 | Fluad, Flucelvax |
| Exact Sciences Corporation | $22.71 | 2025 | The Cologuard Plus Collection Kit |
| Amag Pharmaceuticals, INC. | $19.44 | 2019 | |
| Millicent US INC | $16.83 | 2025 | Intrarosa |
| Ferring Pharmaceuticals INC. | $16.33 | 2019 | |
| Channel Medsystems, INC. | $14.65 | 2023 | |
| Monaghan Medical Corporation | $14.45 | 2023 | Aerobika |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.